BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

Hyundai Bioscience Advances Xafty® as Sole Oral COVID-19 Treatment for High-Risk Patients Ineligible for Paxlovid®

"Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patients who cannot take Paxlovid®" "While maintaining...

August 29, 2024 | News

Zuellig Pharma Secures Exclusive Distribution Agreement with Regeneron to Launch Libtayo® in South Korea and Taiwan

Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owne...

August 28, 2024 | News

Telix Pharmaceuticals Submits NDA to FDA for Innovative Brain Cancer Imaging Agent Pixclara®

Telix Pharmaceuticals announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for ...

August 28, 2024 | News

ArkBio CEO Presents Promising IPF Drug AK3280 at 8th Annual IPF Summit in Boston

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio"), a privately held, clinical-stage biopharmaceutical company today announced that Dr. Jim Wu, Chief...

August 27, 2024 | News

Dr. Reddy’s, Aurigene, and Kainomyx Partner to Develop Affordable Anti-Malarial Drug for Global Public Health

Malaria is a life-threatening public health issue, particularly in low- and middle-income countries. There is a need for an effective, affordable, ...

August 21, 2024 | News

Kelun-Biotech's NDA for Sacituzumab Tirumotecan Accepted by China's NMPA Following Positive Lung Cancer Study Results

New drug application (NDA) for the core product sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) based on the positive results from the pivotal O...

August 21, 2024 | News

AbbVie Secures EU Approval for TEPKINLY® as First Subcutaneous Bispecific Antibody for Relapsed Follicular Lymphoma

AbbVie announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy fo...

August 20, 2024 | News

AbbVie Secures EU Approval for TEPKINLY® as First Subcutaneous Bispecific Antibody for Relapsed Follicular Lymphoma

AbbVie announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy fo...

August 20, 2024 | News

Astellas Pharma Gains NMPA Approval for PADCEV™ in China to Treat Advanced Urothelial Cancer

Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas") announced that the Center for Drug Evaluation (CDE) of C...

August 20, 2024 | News

Akeso’s Ivonescimab Granted Priority Review by China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC

Akeso, Inc. announced that the National Center for Drug Evaluation of the State Drug Administration of the People's Republic of China (NMPA CDE) ...

August 15, 2024 | News

AI Meets Life Sciences: How HKSTP and BioMap Are Transforming Hong Kong’s Biotech Landscape

In an exclusive interview with BioPharma APAC, Dr. Grace Lau, Head of Institute for Translational Research at Hong Kong Science and Technology Parks Corpor...

August 14, 2024 | Interview

UAE Approves LEQEMBI® for Early Alzheimer’s Treatment, Marking a Milestone in Regional Healthcare

Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved humanized anti-so...

August 14, 2024 | News

Sable Therapeutics Secures Exclusive Worldwide Licensing Deal with Columbia University to Advance Cutting-Edge Fat Reduction Nanomedicines

Sable Therapeutics, an innovative early stage drug development company focused on pioneering fat reduction therapies, announced an exclusive worldwid...

August 12, 2024 | News

Formosa Pharmaceuticals and Eyenovia to Co-Develop Clobetasol Propionate for Dry Eye Disease

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has signed a non-binding terms agreement with Eyenovia, Inc. ("...

August 08, 2024 | News

Stay Connected